Apoptotic Signaling Across Breast Cancer Subtypes and Cryoablation-Induced Tissue Injury

Agata Panfil1, Kacper Boroń2,3,4,5, Tomasz Sirek1,2,6

  • 1Collegium Medicum, WSB University, 41-300 Dąbrowa Górnicza, Poland.

Insights

Breast cancer progression shows altered apoptosis signaling, with reduced pro-apoptotic activity and increased stress adaptation in aggressive tumors. This contrasts with transient systemic responses observed after benign fibroadenoma cryoablation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Apoptosis is crucial for tissue homeostasis; its dysregulation drives breast cancer progression and therapeutic resistance.
  • Understanding apoptosis signaling across breast cancer subtypes is vital for targeted therapies.

Purpose of the Study:

  • To investigate apoptosis-related signaling patterns in breast cancer molecular subtypes.
  • To compare malignant apoptosis dysregulation with systemic responses to benign tissue injury (cryoablation).

Main Methods:

  • Integrative analysis of gene expression (mRNA microarrays, qRT-PCR) and protein levels (ELISA) in breast cancer tissues.
  • Assessment of apoptosis pathway activity using MSigDB HALLMARK_APOPTOSIS gene set, intrinsic/extrinsic pathway scoring, and apoptotic balance index (ABI).
  • MicroRNA profiling and in silico analyses to identify miRNA-mRNA interactions.

Main Results:

  • Aggressive breast cancers exhibit reduced pro-apoptotic signaling and increased stress-adaptive responses, particularly in triple-negative and HER2-positive subtypes.
  • Key findings include decreased intrinsic pathway activity, lower ABI, downregulation of pro-apoptotic genes (BIK, BMF, TXNIP), and upregulation of stress genes (HSPB1, PPT1).
  • Overexpression of specific miRNAs (e.g., miR-582-5p, miR-421) correlated with apoptosis-related gene expression changes.

Conclusions:

  • Breast cancer malignancy is characterized by distinct apoptosis pathway dysregulation compared to the transient systemic responses seen after benign fibroadenoma cryoablation.
  • Findings identify potential molecular networks (miRNA-mRNA interactions) involved in breast cancer progression and therapeutic resistance.
  • Pathway-level interpretation highlights differences between malignant dysregulation and regulated physiological responses.